# CStone and Kimia Therapeutics Enter Clinical Development Collaboration to Advance a Novel Drug Candidate Targeting Repair Pathways Critical for Solid Tumor Survival

- Source: PR Newswire M&A
- Published: 2026-11-04T00:10:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/cstone-and-kimia-therapeutics-enter-clinical-development-collaboration-to-advance-a-novel-drug-candidate-targeting-repair-pathways-critical-for-solid-tumor-survival-302927961.html
- Canonical: https://groundlevelnews.com/story/cstone-and-kimia-therapeutics-enter-clinical-development-collaboration-b3d612/

SUZHOU, China, Nov. 3, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas, today announced that it has...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._